Immune Regulation News 1.07, November 27, 2009. Click here if you are unable to see images in this e-mail.

TOP STORIES

What B Cells Can Tell Us About Certain Cancers and Autoimmune Diseases
Researchers have identified an important checkpoint in the B cell development process, where the body gets rid of rogue B cells which see 'self' as the enemy and so allow the body to attack itself - as in autoimmune diseases such as lupus. [The Garvan Institute of Medical Research, Sydney]

Request A Poster  
Isolate Untouched Cells for
Antigen Processing and Presentation
with EasySep®
 
 
REQUEST A POSTER STEMCELL Technologies Inc
 



SPECIAL FEATURE

Video: The EasySep® Pour-off - A Simple and Effective Way to Isolate Cells



SCIENCE NEWS

UAB Researchers Discover Antibody Receptor Identity, Propose Renaming Immune-System Gene
Researchers have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. [University of Alabama at Birmingham, Birmingham]

A Clue in the Multiple Sclerosis Mystery
Nature Immunology research showed that if a mouse has Th17 cells, but these cells cannot get into the choroid plexus, MS is blocked. [The Dana Foundation, New York]

EasySep_645x110_v01




CURRENT PUBLICATIONS

Decrease of Foxp3+ Treg Cell Number and Acquisition of Effector Cell Phenotype during Lethal Infection
During highly T helper 1 (Th1) cell-polarized mucosal immune responses, Treg cell numbers collapsed via multiple pathways, including blockade of Treg cell induction and disruption of endogenous Treg cell homeostasis. [Immunity]

Autologous Mesenchymal Stem Cell Treatment Increased T Regulatory Cells with No Effect on Disease Activity in Two Systemic Lupus Erythematosus Patients
Scientists evaluate the safety and efficacy of bone marrow-derived Mesenchymal stem cells in two human systemic lupus erythematosus patients; the suppressor effect of these cells in-vitro and the change in CD4+CD25+FoxP3+ T regulatory cells in response to treatment. [Lupus]

Structural Basis of Receptor Sharing by Interleukin 17 Cytokines
Interleukin 17 (IL-17)-producing helper T cells (TH-17 cells), together with their effector cytokines, including members of the IL-17 family, are emerging as key mediators of chronic inflammatory and autoimmune disorders. Researchers idenfity the crystal structure of a complex of IL-17 receptor A (IL-17RA) bound to IL-17F in a 1:2 stoichiometry. [Nat Immunol]

Dock8 Mutations Cripple B Cell Immunological Synapses, Germinal Centers and Long-Lived Antibody Production
To identify genes and mechanisms involved in humoral immunity, researchers performed a mouse genetic screen for mutations that do not affect the first wave of antibody to immunization but disrupt response maturation and persistence. [Nat Immunol]

P-Selectin Glycoprotein Ligand-1 Negatively Regulates T Cell Immune Responses
Results reveal a novel regulatory role for P-selectin glycoprotein ligand-1 (PSGL-1) in T cell adhesion and proliferation and suggest that PSGL-1 negatively regulates T cell immune responses in vivo. [J Immunol]

Coactivation of Syk Kinase and MyD88 Adaptor Protein Pathways by Bacteria Promotes Regulatory Properties of Neutrophils
During a chronic infection, neutrophil depletion promoted inflammation and decreased the mycobacterial burden. Therefore, neutrophils can have a previously unsuspected regulatory role during acute and chronic microbial infections. [Immunity]

RoboSep_645x110_v01




INDUSTRY NEWS

Cytheris Announces Initiation of NCI/NIH-Sponsored Phase I/IIa Clinical Study of Tumor Vaccination and Interleukin-7 (IL-7) in Patients with High Risk Pediatric Solid Tumors
Oncology study to focus on use of IL-7 (CYT107) as a vaccine enhancer in effort to develop improved outcomes for disease states in which <20% of patients with metastatic disease are cured.



POLICY NEWS

LRI Announces 2009 Novel Research Grants
The Lupus Research Institute (LRI) today named 12 new grant recipients for 2009. The awards, totaling $3.6 million, recognize innovative work across a broad spectrum of lupus research.



EVENTS

Australasian Society for Immunology Meeting 2009 
December 6-10, 2009
Gold Coast, Australia

9th International Conference on New Trends in Immunosuppression and Immunotherapy
February 4-7, 2010
Geneva, Switzerland

13th International Conference on Lymphocyte Activation and Immune Regulation: Inflammasome and Inflammation
February 5-7, 2010
Newport Beach, United States

Keystone Symposium: Tolerance and Autoimmunity
February 21-26, 2010
Taos, United States

World Immune Regulation Meeting-IV
March 29-April 1, 2010
Davos, Switzerland

IMMUNOLOGY 2010
May 7-11, 2010
Baltimore, United States

14th International Congress of Immunology
August 22-27, 2010
Kobe, Japan

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.


JOB OPPORTUNITIES

Manager, Market Segment Regenerative Medicine (Sigma-Aldrich Corporation)

Technical Specialist (AABB)

R&D Scientist (STEMCELL Technologies)

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization's career opportunities with Cell Therapy News.
Visit here to post your career opportunities.


Have we missed an important article or publication in Immune Regulation News? Click here to submit!

 
forwardafriendicon